Does Dr. CARLOS FERNANDEZ SANTOS have financial conflicts of interest?

Dr. CARLOS FERNANDEZ SANTOS (M.D.) has received a total of $2,834 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $2,834 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. CARLOS FERNANDEZ SANTOS?

According to CMS Open Payments data, Dr. CARLOS FERNANDEZ SANTOS received funding from GENENTECH USA ($593), MALLINCKRODT HOSPITAL PRODUCTS ($447), and ALCON PUERTO RICO ($346).

Does Dr. CARLOS FERNANDEZ SANTOS receive research grants or speaking fees?

Dr. CARLOS FERNANDEZ SANTOS has received $2,834 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. CARLOS FERNANDEZ SANTOS

M.D.Real-Time Hydrated

Specialty: Ophthalmology, Retina Specialist

Practice Location: CAGUAS, PR 00725

NPI Number: 1649566977

LIFETIME INDUSTRY VALUE

$2,834

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. FERNANDEZ SANTOS is a verified Ophthalmology, Retina Specialist practitioner based in CAGUAS, PR.

Between 2021 and 2025, Dr. FERNANDEZ SANTOS had an overall industry promotional and research financial footprint of $2,834 as recorded in the federal CMS Open Payments database.

$2,834 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. FERNANDEZ SANTOS's primary funding source is GENENTECH USA, which accounts for $593 (representing 20.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GENENTECH USA

Rank 1

$593

20.9%

MALLINCKRODT HOSPITAL PRODUCTS

Rank 2

$447

15.8%

ALCON PUERTO RICO

Rank 3

$346

12.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.